Anoro Ellipta 62.5/25 mcg is a prescription inhaler designed to manage Chronic Obstructive Pulmonary Disease (COPD). It contains two bronchodilators, Umeclidinium (62.5 mcg) and Vilanterol (25 mcg), belonging to the Long-Acting Muscarinic Antagonist (LAMA) or anticholinergic and Long-Acting Beta-Agonist (LABA) classes, respectively. This dual-action mechanism helps keep airways open, making breathing easier for patients with COPD.
It is manufactured by GlaxoSmithKline in WHO-certified facilities. It is not intended for treating Asthma or sudden breathing difficulties. It provides 24-hour bronchodilation and is recommended as a maintenance therapy rather than a rescue inhaler.
Umeclidinium works by blocking muscarinic (M3) receptors, reducing airway constriction. Vilanterol stimulates beta-2 receptors, relaxing airway muscles and improving airflow. Together, they enhance lung function, reduce breathlessness, and help prevent COPD flare-ups.
It is prescribed for people with moderate to severe COPD, including chronic bronchitis and emphysema, where persistent airflow obstruction makes daily activities challenging.
The inhaler contains pre-measured doses, making it easy to use. It is available as a dry powder inhaler that is meant for once-daily use. However, it is essential to use it consistently at the same time each day for maximum effectiveness.
It should also be used with caution in patients with heart disease, High Blood Pressure, or certain eye conditions like Glaucoma. Additionally, individuals with urinary retention issues should consult a doctor before using this inhaler, as Umeclidinium may worsen symptoms.
Anoro Ellipta is a chronic respiratory treatment that offers significant benefits for individuals suffering from COPD. By combining two different bronchodilators, it effectively opens up the airways, making breathing easier.
The medication works by preventing airway constriction and ensuring smooth airflow, which leads to better lung function. This allows COPD patients to engage in daily activities with less breathlessness and fatigue.
Another one of Anoro Ellipta 62.5/25 benefits is its ability to reduce the frequency of COPD flare-ups, which can be severe and require hospitalization. Studies have shown that regular use of Anoro Ellipta improves exercise capacity, enabling patients to move around more comfortably without experiencing shortness of breath.
Since it is a once-daily inhaler, it offers ease of use, ensuring better dose compliance compared to multiple-dose inhalers. Over time, the use of Anoro Ellipta can improve the quality of life by enhancing lung efficiency and preventing the worsening of symptoms.
Anoro Ellipta is a long-acting bronchodilator for COPD that should be taken correctly to ensure that you receive its full benefits. Following the correct technique is essential for effective medication delivery.
You can find this lung health support medication in another strength of 55mcg/22mcg on Cheap Medicine Shop.
| $4.44 per dose |
There are no substitutes available.
Using Anoro Ellipta 62.5/25 mcg can significantly improve breathing, but like all medications, it may cause some side effects. Most side effects are mild and tend to improve as the body adjusts to the medication. These include:
However, some people may experience discomfort that requires medical attention. If you notice any unusual symptoms or if side effects do not go away, consult your healthcare provider immediately.
Liver disease
Individuals with liver disorders should exercise caution when using Anoro Ellipta. It is advised that you should get medical advice before taking this medicine if you have any pre-existing liver conditions.
Kidney impairment
Anoro Ellipta 62.5/25 is usually well tolerated by those with kidney issues. However, patients with severe renal impairment should consult their doctor before use.
Pregnant and breastfeeding women
The effects of Anoro Ellipta during pregnancy and breastfeeding are not fully understood. Although no definitive risks have been established, it should only be used if a healthcare professional recommends it.
Avoid
Alcohol consumption while taking Anoro Ellipta may heighten the chances of dizziness, drowsiness, and loss of coordination.
Yes, but Anoro Ellipta may cause increased blood sugar levels in some patients. If you already have Diabetes, observe your blood sugar levels regularly and inform your doctor in case you notice any changes.
No, Anoro Ellipta does not contain steroids or addictive substances. However, it must be used daily for effective COPD management. Stopping it abruptly may cause breathing issues, so always follow your doctor’s guidance.
Yes, most common painkillers (e.g., paracetamol) are safe with Anoro Ellipta. However, Non-Steroidal Anti-inflammatory drugs (NSAIDs) like ibuprofen may worsen breathing issues in some COPD patients. Always consult your doctor before taking any new medications.
Yes, Anoro Ellipta may sometimes increase intraocular pressure, which can worsen vision in patients already suffering from Glaucoma. In case you experience blurred vision, any eye pain, or halos around lights, seek medical attention immediately.
No, while Anoro Ellipta is a breathing aid for COPD symptoms, smoking worsens lung function and reduces the inhaler’s effectiveness. It is strongly advised to quit smoking to improve treatment outcomes and overall lung health.
Yes, moderate exercise can improve lung function and overall health in COPD patients. However, avoid strenuous activities if you experience shortness of breath. Always follow your doctor’s advice on safe physical activity levels.